Universitätsklinikum Essen

Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe (2017) Becker JC, Lorenz E, Ugurel S, Eigentler TK, Kiecker F, Pfoehler C, Kellner I, et al. Journal article Systematic screening of isogenic cancer cells identifies DUSP6 as context-specific synthetic lethal target in melanoma (2017) Wittig-Blaich S, Wittig R, Schmidt S, Lyer S, Bewerunge-Hudler M, Gronert-Sum S, Strobel-Freidekind O, et al. Journal article Targeted Intraoperative Radiotherapy Tumour Bed Boost during Breast-Conserving Surgery after Neoadjuvant Chemotherapy - a Subgroup Analysis of Hormone Receptor-Positive HER2-Negative Breast Cancer (2017) Kolberg HC, Loevey G, Akpolat-Basci L, Stephanou M, Fasching P, Untch M, Hoffmann O, et al. Journal article Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer (2017) Banys-Paluchowski M, Witzel I, Riethdorf S, Rack B, Janni W, Fasching P, Solomayer EF, et al. Journal article Antibody-based immunotherapy of aciclovir resistant ocular herpes simplex virus infections (2017) Bauer D, Keller J, Alt M, Schubert A, Aufderhorst UW, Palapys V, Kasper M, et al. Journal article Statement of the German Contact Dermatitis Research Group (DKG) and the German Dermatological Society (DDG) on liability issues associated with patch testing using a patient's own materials (2017) Mahler V, Dickel H, Diepgen TL, Hillen U, Geier J, Kaufmann R, Kreft B, et al. Journal article Analysis of the German DRG data for livedoid vasculopathy and calciphylaxis (2017) Renner R, Dissemond J, Goerge T, Hoff N, Kroeger K, Erfurt-Berge C Journal article DIFFUSING CAPACITY AND CLINICAL CHARACTERISTICS OF PATIENTS WITH SYSTEMIC SCLEROSIS - DATA FROM THE GERMAN NETWORK FOR SYSTEMIC SCLEROSIS (2017) Moinzadeh P, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, Schmalzing M, et al. Conference contribution Extension study to the open-label, multi-center, expanded access study of everolimus in patients with advanced neuroendocrine tumors (2017) Doerffel Y, Kullmann F, Lammert F, Quietzsch D, Schöfl C, Schuppert F, Weber M, et al. Conference contribution Combined lanreotide autogel and temozolomide in progressive neuroendocrine tumours: an interim safety analysis of the SONNET study (2017) Hoersch D, Raderer M, Lahner H, Rinke A, Denecke T, Koch A, Raspel A, et al. Conference contribution